amygdalin has been researched along with Atherogenesis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Deng, J; Deng, S; Hao, E; Huang, X; Lei, T; Lv, J; Sun, M; Wang, H; Wang, Y; Wang, Z; Xiong, W | 1 |
Bao, C; Du, Z; Hao, E; Jiagang, D; Li, C; Lv, J; Wang, H; Wang, Y | 1 |
2 other study(ies) available for amygdalin and Atherogenesis
Article | Year |
---|---|
Amygdalin ameliorates the progression of atherosclerosis in LDL receptor‑deficient mice.
Topics: Amygdalin; Animals; Atherosclerosis; Biomarkers; Cytokines; Disease Models, Animal; Disease Progression; Lipid Metabolism; Male; Mice; Mice, Knockout; Receptors, LDL; RNA, Messenger; T-Lymphocytes, Regulatory | 2017 |
Amygdalin mediates relieved atherosclerosis in apolipoprotein E deficient mice through the induction of regulatory T cells.
Topics: Amygdalin; Animals; Apolipoproteins E; Apoptosis; Atherosclerosis; Forkhead Transcription Factors; Lipids; Lymphocyte Activation; Male; Mice; Mice, Mutant Strains; T-Lymphocytes, Regulatory | 2011 |